Lori Leaseburge, MD
Obstetrics · Jacksonville, FLNPI 1275628455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations.
Across 132 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$304
- Astellas Pharma US Inc$181
- Axsome Therapeutics, Inc.$175
- Novo Nordisk$147
- AbbVie$145
- Therapeuticsmd, Inc.$130
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,28899%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 17 | $304 |
| Astellas Pharma US Inc | 9 | $181 |
| Axsome Therapeutics, Inc. | 8 | $175 |
| Novo Nordisk | 8 | $147 |
| AbbVie | 11 | $145 |
| Therapeuticsmd, Inc. | 8 | $130 |
| Exact Sciences | 7 | $122 |
| Corcept Therapeutics | 6 | $118 |
| Acella Pharmaceuticals, LLC | 6 | $97 |
| Exeltis, USA Inc. | 5 | $78 |
| Mayne Pharma Commercial LLC | 3 | $72 |
| Endo Pharmaceuticals Inc. | 4 | $67 |
| Hologic Sales And Service, LLC | 4 | $65 |
| Bayer | 3 | $63 |
| Vertical Pharmaceuticals, LLC | 3 | $49 |
| Acerus Pharmaceuticals Corporation | 3 | $46 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Millicent US Inc | 2 | $41 |
| Coloplast | 1 | $35 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Ascend Therapeutics US, LLC | 2 | $26 |
| Clarus Therapeutics Inc. | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Avion Pharmaceuticals | 2 | $26 |
| Concordia Pharmaceuticals Inc. | 2 | $25 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Vivus LLC | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Amgen | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,300 in reported general payments places this provider in the 65th percentile of 78 obstetrics providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 500 | $13,125 |
| Estradiol (Twice Weekly)Estradiol | 138 | $11,181 |
| Estradiol | 81 | $6,594 |
| Estradiol (Once Weekly)Estradiol | 74 | $5,719 |
| MyrbetriqMirabegron | 11 | $4,888 |
| SynthroidLevothyroxine Sodium | 30 | $3,390 |
| Armour ThyroidThyroid,pork | 31 | $2,535 |
| DottiEstradiol | 21 | $1,896 |
| Liothyronine Sodium | 46 | $1,865 |
| Levothyroxine Sodium | 139 | $1,271 |
| Np ThyroidThyroid,pork | 20 | $994 |
| ValacyclovirValacyclovir Hcl | 30 | $823 |
| LyllanaEstradiol | 11 | $473 |
| Clobetasol Propionate | 24 | $394 |
| Escitalopram Oxalate | 18 | $291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid, Armour Thyroid | $145 | $5,92561 claims |
| Astellas Pharma US IncMyrbetriq | $181 | $4,88811 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $1,271139 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $97 | $99420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 78 obstetrics providers in Florida.
Other obstetrics in Jacksonville
- Sasha GourgueJacksonville$4K
- Reuben BrigetyJacksonville$766
- Wilkens MondesirGreenacres$16K
- Phan NguyenNaples$14K
- Nasim KhanSebring$11K
- Ivonne ReynoldsMargate$11K
- Robert FeldmanSouth Miami$10K
- Isidro MartinezMiami$10K
- Michele LemayBradenton$10K
- Kyle GarnerSarasota$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.